HK1187340A1 - 作為 受體配體的雜芳基化合物 - Google Patents
作為 受體配體的雜芳基化合物Info
- Publication number
- HK1187340A1 HK1187340A1 HK14100305.4A HK14100305A HK1187340A1 HK 1187340 A1 HK1187340 A1 HK 1187340A1 HK 14100305 A HK14100305 A HK 14100305A HK 1187340 A1 HK1187340 A1 HK 1187340A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- receptor ligands
- heteroaryl compounds
- heteroaryl
- compounds
- ligands
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3203CH2011 | 2011-09-19 | ||
| PCT/IN2012/000011 WO2013042135A1 (en) | 2011-09-19 | 2012-01-05 | Heteroaryl compounds as 5-ht4 receptor ligands |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1187340A1 true HK1187340A1 (zh) | 2014-04-04 |
Family
ID=46001349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14100305.4A HK1187340A1 (zh) | 2011-09-19 | 2014-01-10 | 作為 受體配體的雜芳基化合物 |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9079894B2 (zh) |
| EP (1) | EP2758394B1 (zh) |
| JP (1) | JP5714729B2 (zh) |
| KR (1) | KR101551481B1 (zh) |
| CN (1) | CN103380131B (zh) |
| AP (1) | AP3307A (zh) |
| AU (1) | AU2012311057B2 (zh) |
| BR (1) | BR112014001083B8 (zh) |
| CA (1) | CA2823548C (zh) |
| CY (1) | CY1116173T1 (zh) |
| DK (1) | DK2758394T3 (zh) |
| EA (1) | EA022374B1 (zh) |
| ES (1) | ES2531885T3 (zh) |
| HK (1) | HK1187340A1 (zh) |
| HR (1) | HRP20150229T1 (zh) |
| IL (1) | IL231305A0 (zh) |
| ME (1) | ME02107B (zh) |
| MX (1) | MX337721B (zh) |
| PL (1) | PL2758394T3 (zh) |
| PT (1) | PT2758394E (zh) |
| RS (1) | RS53940B1 (zh) |
| SG (1) | SG2014003560A (zh) |
| SI (1) | SI2758394T1 (zh) |
| SM (1) | SMT201500087B (zh) |
| WO (1) | WO2013042135A1 (zh) |
| ZA (1) | ZA201309100B (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012267797A1 (en) * | 2011-06-07 | 2014-01-09 | Sumitomo Dainippon Pharma Co., Ltd. | Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof |
| CN105120851A (zh) * | 2013-04-05 | 2015-12-02 | Abc生物科学公司 | 用于医疗用途，具体为用于治疗与氧化应激相关的疾病或者炎症和用于保存或者洗涤器官的barettin及其衍生物 |
| CA2932428C (en) | 2013-12-16 | 2017-10-24 | Suven Life Sciences Limited | Indazole compounds as 5-ht4 receptor agonists |
| PL3180333T3 (pl) | 2014-08-16 | 2020-12-28 | Suven Life Sciences Limited | Proces przygotowania na dużą skalę szczawianu 1-izopropylo-3-{5- [1-(3-metoksypropylo) piperydyn-4-ylo]-[1,3,4]oksadiazol-2-ilo}-1h-indazolu |
| PL3265459T3 (pl) * | 2015-02-13 | 2019-09-30 | Suven Life Sciences Limited | Związki amidowe jako agoniści receptora 5-HT4 |
| CN107540568A (zh) * | 2017-08-25 | 2018-01-05 | 许昌恒生制药有限公司 | 一种乙氧酰胺苯甲酯的制备方法 |
| JP2022505388A (ja) * | 2018-10-18 | 2022-01-14 | スヴェン・ライフ・サイエンシーズ・リミテッド | ５－ｈｔ４受容体アゴニストの新しい使用 |
| CA3141826A1 (en) | 2019-05-31 | 2020-12-03 | Ikena Oncology, Inc. | Tead inhibitors and uses thereof |
| CN110746450A (zh) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | 一种贝前列素钠关键中间体的合成方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0596933A1 (en) * | 1991-08-03 | 1994-05-18 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
| TW360653B (en) * | 1995-03-01 | 1999-06-11 | Janssen Pharmaceutica Nv | A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition |
| BR9611311A (pt) | 1995-11-09 | 1999-06-29 | Synthelabo | Derivados de 5-fenil-3-(piperidin-4-il)-1,3,4-oxadiazol-2(3h)-ona úteis como ligantes dos receptores 5-ht4 ou h3 |
| GB0115862D0 (en) * | 2001-06-28 | 2001-08-22 | Smithkline Beecham Plc | Compounds |
| WO2005049608A1 (en) | 2003-11-24 | 2005-06-02 | Pfizer Japan, Inc. | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity |
| EP1856110B1 (en) | 2005-02-22 | 2011-06-22 | Pfizer Inc. | Oxyindole derivatives as 5ht4 receptor agonists |
| US8816090B2 (en) | 2005-02-25 | 2014-08-26 | Pfizer Inc. | Benzisoxazole derivatives |
| ES2333545T3 (es) | 2005-07-22 | 2010-02-23 | Pfizer, Inc. | Derivados de indazolcarboxamida como agonistas de receptores 5ht4. |
| ES2397401T3 (es) * | 2005-12-23 | 2013-03-06 | F. Hoffmann-La Roche Ag | Derivados de aril-isoxazol-4-il-oxadiazol |
| US20080167286A1 (en) * | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
| US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
| JP5656880B2 (ja) * | 2009-03-09 | 2015-01-21 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | Ｐｉ３キナーゼの阻害剤としての４−オキサジアゾール−２−イル−インダゾール |
-
2012
- 2012-01-05 JP JP2013554062A patent/JP5714729B2/ja active Active
- 2012-01-05 PL PL12716662T patent/PL2758394T3/pl unknown
- 2012-01-05 AP AP2013007301A patent/AP3307A/xx active
- 2012-01-05 ES ES12716662.7T patent/ES2531885T3/es active Active
- 2012-01-05 CA CA2823548A patent/CA2823548C/en active Active
- 2012-01-05 BR BR112014001083A patent/BR112014001083B8/pt not_active IP Right Cessation
- 2012-01-05 EA EA201391056A patent/EA022374B1/ru unknown
- 2012-01-05 SG SG2014003560A patent/SG2014003560A/en unknown
- 2012-01-05 US US13/982,486 patent/US9079894B2/en active Active
- 2012-01-05 DK DK12716662.7T patent/DK2758394T3/en active
- 2012-01-05 KR KR1020137020582A patent/KR101551481B1/ko active IP Right Grant
- 2012-01-05 AU AU2012311057A patent/AU2012311057B2/en active Active
- 2012-01-05 CN CN201280009072.1A patent/CN103380131B/zh active Active
- 2012-01-05 EP EP12716662.7A patent/EP2758394B1/en active Active
- 2012-01-05 WO PCT/IN2012/000011 patent/WO2013042135A1/en active Application Filing
- 2012-01-05 MX MX2013014577A patent/MX337721B/es active IP Right Grant
- 2012-01-05 PT PT127166627T patent/PT2758394E/pt unknown
- 2012-01-05 ME MEP-2015-47A patent/ME02107B/me unknown
- 2012-01-05 SI SI201230163T patent/SI2758394T1/sl unknown
- 2012-01-05 RS RS20150234A patent/RS53940B1/en unknown
-
2013
- 2013-12-04 ZA ZA2013/09100A patent/ZA201309100B/en unknown
-
2014
- 2014-01-10 HK HK14100305.4A patent/HK1187340A1/zh unknown
- 2014-03-04 IL IL231305A patent/IL231305A0/en active IP Right Grant
-
2015
- 2015-02-26 HR HRP20150229AT patent/HRP20150229T1/hr unknown
- 2015-03-30 CY CY20151100308T patent/CY1116173T1/el unknown
- 2015-04-09 SM SM201500087T patent/SMT201500087B/xx unknown
- 2015-06-10 US US14/735,237 patent/US9636335B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL286152A (en) | Modified imidazopyridinyl-aminopyridine compounds | |
| GB201106799D0 (en) | Novel compounds | |
| GB201107325D0 (en) | Novel compounds | |
| AP3307A (en) | Heteroaryl compounds as 5-HT4 receptor ligands | |
| EP2670746A4 (en) | BICYCLIC HETEROARYL COMPOUNDS AS GPR119 RECEPTOR AGONISTS | |
| HK1187613A1 (zh) | 作為組胺 受體配體的化合物 | |
| EP2717694A4 (en) | NEW COMPOUNDS | |
| HK1180955A1 (zh) | 作為組胺 受體配體的雜環基化合物 | |
| HUP1100731A2 (en) | Complex forming compounds | |
| TH1401001203B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
| TH148768B (th) | สารประกอบเฮเทอโรเอริลในฐานะที่เป็น 5-ht4 รีเซปเตอร์ลิแกนด์ | |
| GB201111410D0 (en) | Novel compounds | |
| GB201111409D0 (en) | Novel compounds | |
| GB201111308D0 (en) | Novel compounds | |
| GB201111229D0 (en) | Novel compounds | |
| GB201109508D0 (en) | Novel compounds | |
| GB201109514D0 (en) | Novel compounds | |
| GB201106801D0 (en) | Novel compounds | |
| GB201104138D0 (en) | Novel compounds | |
| GB201103283D0 (en) | Novel compounds | |
| GB201103073D0 (en) | Novel compounds | |
| GB201101640D0 (en) | Novel compounds | |
| GB201101085D0 (en) | Novel compounds |